Christopher-Michael Gale
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Kreshnik Zejnullahu (4 shared papers)Pasi Antero Janne (4 shared papers)Jeffrey A. Engelman (3 shared papers)Lewis C. Cantley (3 shared papers)Bruce Evan Johnson (2 shared papers)Charles Lee (2 shared papers)Tetsuya Mitsudomi (2 shared papers)Joon Oh Park (2 shared papers)
- Journals
- Journal of Clinical Investigation (1 paper)Cancer Research (1 paper)Science (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Christopher-Michael Gale
4 papers receiving 4.8k citations
Christopher-Michael Gale's Hit Papers
Peers
Comparison fields: 5 of 78
- Pulmonary and Respiratory Medicine 3k
- Oncology 995
- Cancer Research 388
- Pathology and Forensic Medicine 306
- Hepatology 132
Countries citing papers authored by Christopher-Michael Gale
This map shows the geographic impact of Christopher-Michael Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher-Michael Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher-Michael Gale more than expected).
Fields of papers citing papers by Christopher-Michael Gale
This network shows the impact of papers produced by Christopher-Michael Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher-Michael Gale. The network helps show where Christopher-Michael Gale may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher-Michael Gale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Hit paper breakdown → | 2007 | 3895 |
| 2 | PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib Hit paper breakdown → | 2007 | 652 |
| 3 | 2006 | 405 | |
| 4 | 2007 | 1 |
About Christopher-Michael Gale
Christopher-Michael Gale is a scholar working on Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering, Waste Management and Disposal, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3k citations), Oncology (995 citations), Cancer Research (388 citations), Pathology and Forensic Medicine (306 citations) and Hepatology (132 citations). Christopher-Michael Gale has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Kreshnik Zejnullahu, Pasi Antero Janne, Jeffrey A. Engelman, Lewis C. Cantley, Bruce Evan Johnson, Charles Lee, Tetsuya Mitsudomi, Joon Oh Park, Youngchul Song and Takayuki Kosaka. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research, Science and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.